It has been established that TRZ inhibits Aβ-induced BIR and associated synaptic dysfunction, memory dysfunction, and cognitive impairment by restoring the PI3 K/AKT/GSK3β signaling pathway in the AD mouse model (Guo et al. 2023). This evidence concerns the gene AKT1 and Alzheimer disease.